A milbemycin compound isolated from Streptomyces Sp. FJS31-2 with cytotoxicity and reversal of cisplatin resistance activity in A549/DDP cells

KIB OpenIR

	A milbemycin compound isolated from Streptomyces Sp. FJS31-2 with cytotoxicity and reversal of cisplatin resistance activity in A549/DDP cells
	Li, Xiao-Qian; Yue, Chang-Wu; Xu, Wen-Hui; Lu, Yu-Hong; Huang, Yan-Jie; Tian, Peng; Liu, Tie
	2020
发表期刊	BIOMEDICINE & PHARMACOTHERAPY
ISSN	0753-3322
学科领域	Research & Experimental Medicine ; Pharmacology & Pharmacy
DOI	10.1016/j.biopha.2020.110322
收录类别	SCI
WOS记录号	WOS:000561740000007
引用统计
文献类型	期刊论文
条目标识符	http://ir.kib.ac.cn/handle/151853/72357
专题	中国科学院昆明植物研究所
推荐引用方式 GB/T 7714	Li, Xiao-Qian,Yue, Chang-Wu,Xu, Wen-Hui,et al. A milbemycin compound isolated from Streptomyces Sp. FJS31-2 with cytotoxicity and reversal of cisplatin resistance activity in A549/DDP cells[J]. BIOMEDICINE & PHARMACOTHERAPY,2020.
APA	Li, Xiao-Qian.,Yue, Chang-Wu.,Xu, Wen-Hui.,Lu, Yu-Hong.,Huang, Yan-Jie.,...&Liu, Tie.(2020).A milbemycin compound isolated from Streptomyces Sp. FJS31-2 with cytotoxicity and reversal of cisplatin resistance activity in A549/DDP cells.BIOMEDICINE & PHARMACOTHERAPY.
MLA	Li, Xiao-Qian,et al."A milbemycin compound isolated from Streptomyces Sp. FJS31-2 with cytotoxicity and reversal of cisplatin resistance activity in A549/DDP cells".BIOMEDICINE & PHARMACOTHERAPY (2020).